Contraste
Acessibility 
Average Target Price - R$ 4.91
| Consensus | 2024E | 2025E |
|---|---|---|
| Net sales (R$ million) | R$ 27,174 | R$ 28,791 |
| Gross margin (%) | 30.9% | 31.2% |
| Adjusted EBITDA (R$ million) | R$ 1,817 | R$ 2,326 |
| Financial result (R$ million) | -R$ 1,367 | -R$ 1,198 |
| Net income (R$ million) | -R$ 871 | -R$ 912 |
TARGET PRICE (Sell) - R$ 6.70
| Banco do Brasil projections | 2024E | 2025E |
|---|---|---|
| Net sales (R$ million) | R$ 26,977 | R$ 28,147 |
| Gross margin (%) | 30.7% | 29.8% |
| Adjusted EBITDA (R$ million) | R$ 1,983 | R$ 2,210 |
| Financial result (R$ million) | R$ (1,743) | R$ (1,934) |
| Net income (R$ million) | R$ (625) | R$ (613) |
TARGET PRICE (Sell) - R$ 3.25
| BofA Merrill Lynch projections | 2024E | 2025E |
|---|---|---|
| Net sales(R$ million) | R$ 26,714 | R$ 28,133 |
| Gross margin (%) | – | – |
| Adjusted EBITDA (R$ million) | – | – |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | -R$ 936 | -R$ 1,266 |
TARGET PRICE (Neutral) - R$ 9.00
| Bradesco projections | 2024E | 2025E |
|---|---|---|
| Net sales (R$ million) | R$ 28,697 | R$ 30,512 |
| Gross margin (%) | – | – |
| Adjusted EBITDA (R$ million) | R$ 2,058 | R$ 3,008 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | -R$ 1.086 | R$ 0 |
TARGET PRICE (Neutral) - R$ 3.00
| BTG Pactual projections | 2024E | 2025E |
|---|---|---|
| Net sales(R$ million) | R$ 27,031 | R$ 28,637 |
| Gross margin (%) | 30.8% | 31.6% |
| Adjusted EBITDA (R$ million) | R$ 1,939 | R$ 2,561 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | R$ (689) | R$ (754) |
TARGET PRICE (Sell) - R$ 4.00
| Genial projections | 2024E | 2025E |
|---|---|---|
| Net sales(R$ million) | R$ 28,156 | R$ 29,715 |
| Gross margin (%) | 30.40% | 31.10% |
| Adjusted EBITDA (R$ million) | R$ 2,114 | R$ 2,692 |
| Financial result (R$ million) | -R$ 2,510 | -R$ 2,326 |
| Net income (R$ million) | -R$ 1,274 | -R$ 602 |
TARGET PRICE (Sell) - R$ 2.90
| Goldman Sachs projections | 2024E | 2025E |
|---|---|---|
| Net sales (R$ million) | R$ 26,827 | R$ 28,285 |
| Gross margin (%) | – | – |
| Adjusted EBITDA (R$ million) | R$ 1,722 | R$ 2,318 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | -R$ 847 | -R$ 1,393 |
TARGET PRICE (Sell) - -
| Morgan Stanley projections | 2024E | 2025E |
|---|---|---|
| Net sales(R$ million) | R$ 26.822 | R$ 28.788 |
| Gross margin (%) | 30.9% | 31.4% |
| Adjusted EBITDA (R$ million) | R$ 1,919 | R$ 2,418 |
| Financial result (R$ million) | R$ (1,945) | R$ (2,928) |
| Net income (R$ million) | R$ (857) | R$ (1.164) |
TARGET PRICE (Sell) - R$ 3.20
| Safra projections | 2024E | 2025E |
|---|---|---|
| Net sales (R$ million) | R$ 26,935 | R$ 28,886 |
| Gross margin (%) | 31.4% | 31.5% |
| Adjusted EBITDA (R$ million) | R$ 2,385 | R$ 2,970 |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | -R$ 861 | -R$ 905 |
TARGET PRICE (Neutral) - R$ 3.90
| Santander projections | 2024E | 2025E |
|---|---|---|
| Net sales(R$ million) | R$ 27,072 | R$ 28,674 |
| Gross margin (%) | 30.9% | 31.5% |
| Adjusted EBITDA (R$ million) | R$ 1,928 | R$ 2,552 |
| Financial result (R$ million) | -R$ 2,004< | -R$ 0 |
| Net income (R$ million) | -R$ 813 | -R$ 1,020 |
TARGET PRICE (Neutral) - R$ 8.00
| XP projections | 2024E | 2025E |
|---|---|---|
| Net sales(R$ million) | R$ 31.377 | – |
| Gross margin (%) | 29.70% | – |
| Adjusted EBITDA (R$ million) | R$ 2.066 | – |
| Financial result (R$ million) | – | – |
| Net income (R$ million) | -R$ 1.051 | -/td> |
